| 영문 | lead poisoning, saturinism | 한글 | 납중독 |
|---|---|---|---|
| 설명 | 용해성 납을 흡입하거나 삼킴으로써 유발되는 직업병. 급성과 만성이 있으며 대량으로 흡수하여 급성 위장염 증상을 나타내는 급성 중독은 오히려 드물고, 극소량(1일 1mg 이하)의 납을 장기간 지속적으로 섭취함으로써 생기는 만성이 더 심각하다. 납제련업-활판인쇄업-도장업-납유리제조업-축전지제조업 등 납 또는 납을 함유한 물질을 다루는 사람, 또 과거에는 연백을 사용한 분에 의한 화장독이 여성에게 나타나 문제가 되었으나, 오늘날에는 가솔린에 혼합된 안티녹제인 사에틸납으로 인한 중독이 주목되고 있다. 사에틸납 중독의 증상은 여러 가지인데, 빈혈이나 떨리는 증상이 비교적 초기에 나타나고 납선(잇몸에 납이 침착하여 청회백색으로 착색된다)이나 발작적 복통이 특징이다. 일반적으로 납의 증기나 가루가 기도를 통해 체내로 들어가는 경우가 도료-안료에 들어 있는 납이 피부나 소화관을 통해 침투하는 증례보다 증상이 심하다. |
||
| ECG | Electro-Cardio-Graphy(-Gram); 심전도 = EKG 1. Conducting System Structu... |
|---|---|
| FOB | fecal occult blood; feet out of bed; fiberoptic bronchoscopy; foot of bed; functional observational ... |
| HRNB | Halstead-Reitan Neuropsychological Battery |
| KABC | Kaufman Assessment Battery for Children |
| LNNB | Luria-Nebraska Neuropsycho-logical Battery |
| ABLES | Adult Blood Lead Epidemiology and Surveillance program |
|---|---|
| BLL | Blood lead level |
| LEAD | Lower extremity arterial disease |
| TEL | Tetraethyl lead |
| CANTAB | Cambridge Neuropsychological Test Auto mated Battery |
| lead storage battery | <chemistry> A battery (used in cars) in which the anode is lead, the cathode is lead coated with lead dioxide, and the electrolyte is a sulfuric acid solution. (09 Jan 1998) |
|---|
| battery | <chemistry> A group of voltaic cells connected in series. (09 Jan 1998) |
|---|---|
| graphite battery | <physics> A voltaic battery consisting of zinc and carbon in sulphuric acid, or other exciting liquid. Source: Websters Dictionary (20 Jun 2000) |
| water battery | 1. <physics> A voltaic battery in which the exciting fluid is water. 2. A battery nearly on a level with the water. Source: Websters Dictionary (01 Mar 1998) |
| luria-nebraska neuropsychological battery | A series of tests designed to assess neuropsychological function. The battery is used to diagnose specific cerebral dysfunction and also to determine lateralization. (12 Dec 1998) |
| brancher glycogen storage disease | Type of glycogen storage disease, due to deficiency of amylo-1,4-1,6-transglucosidase (brancher enzyme). Synonym: brancher deficiency glycogenosis, debrancher deficiency. (05 Mar 2000) |
| glycogen storage disease | <hepatology> A group of inherited metabolic disorders involving the enzymes responsible for the synthesis and degradation of glycogen. In some patients, prominent liver involvement is presented. In others, more generalised storage of glycogen occurs, sometimes with prominent cardiac involvement. Synonym: glycogenosis (12 Sep 2002) |
| glycogen storage disease type I | <disease> An autosomal recessive disease in which gene expression of glucose-6-phosphatase is absent, resulting in hypoglycaemia due to lack of glucose production. Accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly. Increased concentrations of lactic acid and hyperlipidemia appear in the plasma. Clinical gout often appears in early childhood. Inheritance: autosomal recessive. (12 Dec 1998) |
| glycogen storage disease type II | <disease> Glycogenosis due to alpha-1,4-glucosidase (acid maltase) deficiency. It affects muscle, heart, and other organs. (12 Dec 1998) |
| glycogen storage disease type III | <disease> An autosomal recessive metabolic disorder due to deficient expression of amylo-1,6-glucosidase (one part of the glycogen debranching enzyme system). The clinical course of the disease is similar to that of glycogen storage disease type I, but milder. Massive hepatomegaly, which is present in young children, diminishes and occasionally disappears with age. Levels of glycogen with short outer branches are elevated in muscle, liver, and erythrocytes. Six subgroups have been identified, with subgroups type IIIa and type IIIb being the most prevalent. Inheritance: autosomal recessive (12 Dec 1998) |
| glycogen storage disease type IV | <disease> An autosomal recessive metabolic disorder due to a deficiency in expression of branching enzyme (alpha-1,4-glucan-6-alpha-glucosyltransferase), resulting in an accumulation of abnormal glycogen with long outer branches. Clinical features are muscle hypotonia and cirrhosis. Death from liver disease usually occurs before age 2. Inheritance: autosomal recessive (12 Dec 1998) |
| glycogen storage disease type V | <disease> Glycogenosis due to muscle phosphorylase deficiency. Characterised by painful cramps following sustained exercise. Inheritance: autosomal recessive (12 Dec 1998) |
| glycogen storage disease type VI | <disease> A hepatic glycogen storage disease in which there is an apparent deficiency of hepatic phosphorylase activity. However, studies have not been able to distinguish between phosphorylase deficiency and phosphorylase kinase deficiency in patients with hepatic glycogenosis. (12 Dec 1998) |
| glycogen storage disease type VII | <disease> An autosomal recessive muscle glycogen storage disease in which there is deficient expression of muscle phosphofructokinase activity, resulting in increased concentrations of glucose-6-phosphate and fructose-6-phosphate and low concentrations of fructose-1,6-diphosphate in muscle tissue. Glycogen storage in muscle is increased, perhaps due to activation of glycogen synthase by accumulated glucose-6-phosphate. It has been proposed that shunting of glucose-6-phosphate and fructose-6-phosphate into the pentose phosphate pathway may result in increased synthesis of purines and pyrimidines, causing hyperuricaemia and gout. Erythrocytes from patients may show decreased phosphofructokinase activity and 2,3-diphosphoglycerate deficiency. Exercise intolerance is present and severe congenital muscular dystrophy has been reported. Inheritance: autosomal recessive (12 Dec 1998) |
| glycogen storage disease type VIII | <disease> An x-linked recessive hepatic glycogen storage disease resulting from lack of expression of phosphorylase-b-kinase activity. Symptoms are relatively mild; hepatomegaly, increased liver glycogen, and decreased leukocyte phosphorylase are present. Liver shrinkage occurs in response to glucagon. Inheritance: X-linked recessive (12 Dec 1998) |
| cholesterol ester storage disease | A rare benign adult form of inherited lysosomal lipid storage disease that is due to deficiency of acid lipase. It results in an accumulation of neutral lipids, particularly cholesterol esters, within cells (particularly leukocytes, fibroblasts, and liver cells). It is an allelic variant of wolman disease. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|